Lates News

AEON Biopharma (AEON.US): The Q3 financial report in 2025 achieved revenue of 0 US dollars, compared to the previous value of 0 US dollars; earnings per share were -0.39 US dollars, compared to -11.52 US dollars previously, with an expected value of -0.43 US dollars.